CIPROFLOXACIN TEVA 250 MG

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

CIPROFLOXACIN AS HYDROCHLORIDE

MAH:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

ATC_code:

S03AA07

pharmaceutical_form:

TABLETS

composition:

CIPROFLOXACIN AS HYDROCHLORIDE 250 MG

administration_route:

PER OS

prescription_type:

Required

manufactured_by:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

therapeutic_group:

CIPROFLOXACIN

therapeutic_area:

CIPROFLOXACIN

therapeutic_indication:

Broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. Treatment of acute pulmonary exacerbation of cystic fibrosis associated with P. aeruginosa infections in pediatric patients aged 5-17 years.

authorization_date:

2012-03-31